Related references
Note: Only part of the references are listed.Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Clearing the Fog: Is Hydroxychloroquine Effective in Reducing Coronavirus Disease-2019 Progression? A Randomized Controlled Trial
Sultan M. Kamran et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
Eva Schrezenmeier et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Defining the Epidemiology of Covid-19-Studies Needed
Marc Lipsitch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Coronavirus Disease 2019 (COVID-19) in Italy
Edward Livingston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis
Phulen Sarma et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Wei Tang et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Joshua Geleris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Samia Arshad et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil
William Marciel de Souza et al.
NATURE HUMAN BEHAVIOUR (2020)
被撤回的出版物: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study (Retracted article. See vol. 107, pg. 728, 2022)
Sherief Abd-Elsalam et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Masataka Nishiga et al.
NATURE REVIEWS CARDIOLOGY (2020)
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
A. B. Cavalcanti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
No benefit of hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of Randomized Controlled Trials
Subodh Kumar Pathak et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
A metabolic handbook for the COVID-19 pandemic
Janelle S. Ayres
NATURE METABOLISM (2020)
Leflunomide-hydroxychloroquine combination therapy in patients with primary Sjogren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial
Eefje Hanna Martine van der Heijden et al.
LANCET RHEUMATOLOGY (2020)
The effects of methotrexate and hydroxychloroquine combination therapy vs methotrexate monotherapy in early rheumatoid arthritis patients
Lisa Schapink et al.
RHEUMATOLOGY (2019)
The limitations of observation studies for decision making regarding drugs efficacy and safety
Francois Gueyffier et al.
THERAPIE (2019)
Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial
Li-Jun Liu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Effects of Hydroxychloroquine on Proteinuria in Immunoglobulin A Nephropathy
Ya-Zi Yang et al.
AMERICAN JOURNAL OF NEPHROLOGY (2018)
Hydroxychloroquine retinopathy - implications of research advances for rheumatology care
April Jorge et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study
Vinod Ravindran et al.
CLINICAL RHEUMATOLOGY (2017)
Increased Incidence of Gastrointestinal Side Effects in Patients Taking Hydroxychloroquine: A Brand-related Issue?
AMAR SRINIVASA et al.
JOURNAL OF RHEUMATOLOGY (2017)
Effects of Hydroxychloroquine in Patients With Cutaneous Lupus Erythematosus A Multicenter, Double-Blind, Randomized, Parallel-Group Trial
N. Yokogawa et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Hydroxychloroquine-Induced Retinal Toxicity
K. C. Iselin et al.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2016)
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
Michael F. Marmor et al.
OPHTHALMOLOGY (2016)
Hydroxychloroquine retinopathy: A review of imaging
Hemang K. Pandya et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2015)
Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study
E. Cairoli et al.
LUPUS (2015)
Meta-Analysis of the Adverse Effects of Long-Term Azithromycin Use in Patients with Chronic Lung Diseases
Hui Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Hydroxychloroquine-Induced Cardiomyopathy: Case Report, Pathophysiology, Diagnosis, and Treatment
Haran Yogasundaram et al.
CANADIAN JOURNAL OF CARDIOLOGY (2014)
Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone
Anil Pareek et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI)
Naoto Yokogawa et al.
Modern Rheumatology (2014)
Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial
Jacqueline Detert et al.
TRIALS (2014)
Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review
Emer Joyce et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2013)
Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects
C. Tang et al.
INTERNAL MEDICINE JOURNAL (2012)
Hydroxychloroquine administration for Japanese lupus erythematosus in Wakayama: A pilot study
Takaharu Ikeda et al.
JOURNAL OF DERMATOLOGY (2012)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine
I. Cavazzana et al.
LUPUS (2009)
Share Paper
